Rapid growth may be appropriate trigger for treatment in patients with renal...
With an increase in abdominal imaging over the past decade, there has been an increase in the detection of incidental kidney cancer, which has led to concerns that we may be over-treating indolent...
View ArticleOpting to track, not treat, early prostate cancer
(AP) -- John Shoemaker visited six doctors in his quest to find the best treatment for his early stage prostate cancer - and only the last one offered what made the most sense to the California man:...
View ArticleCommonly used drug for enlarged prostate slows growth of early-stage prostate...
Dutasteride, a drug that is commonly used to treat enlargement of the prostate, might also slow the growth of early-stage prostate cancer and reduce the need for potentially debilitating treatments...
View ArticleInvestigational urine test can predict high-risk prostate cancer in men who...
Initial results of a multicenter study coordinated by researchers at Fred Hutchinson Cancer Research Center indicates that two investigational urine-based biomarkers are associated with prostate...
View ArticleCriteria for surveillance of small renal mass examined
(HealthDay) -- Active surveillance of patients with small renal masses is driven by a tumor size less than 3 cm, poor performance score (PS), and an endophytic lesion, among other patient, tumor, and...
View ArticleActive surveillance cost-effective for prostate cancer
(HealthDay) -- In a theoretical cohort of 120,000 men, selecting active surveillance for prostate cancer results in considerable cost savings at five and 10 years of follow-up, compared with immediate...
View ArticleActive surveillance up in multidisciplinary prostate CA care
(HealthDay) -- Men with low-risk prostate cancer are more likely to pursue active surveillance when seen at a multidisciplinary prostate cancer clinic rather than when they see individual specialists...
View ArticleModel confirms active surveillance as viable option for men with low-risk...
A new research model has estimated that the difference in prostate cancer mortality among men with low-risk disease who choose active surveillance versus those who choose immediate treatment with...
View ArticleMRI helps identify patients with prostate cancer who may benefit from active...
PSA screening has resulted in improved prostate cancer survival, but the high rate of diagnosis and treatment side effects raise concerns about overtreatment. In the quest to prevent overtreatment,...
View ArticleResearchers develop prostate cancer testing, treatment guidelines
Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN – The Journal...
View ArticleActive surveillance provides a viable alternative to surgery for small kidney...
Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the...
View ArticleNew prostate cancer test improves risk assessment
(Medical Xpress)—A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test,...
View ArticleObservation is safe, cost-saving in low-risk prostate cancer
Many men with low-risk, localized prostate cancers can safely choose active surveillance or "watchful waiting" instead of undergoing immediate treatment and have better quality of life while reducing...
View ArticleProstate cancer screening: New data support watchful waiting
Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer...
View ArticleProstate cancer tumors' aggressiveness may be inherently fixed
A new study of prostate cancer suggests that a tumor's aggressiveness is inherently fixed at the time of its appearance, although diet, lifestyle and environmental factors may trigger progression of...
View ArticleGenetic test could identify which prostate cancers require treatment
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing, according to researchers at the Herbert Irving...
View ArticleNew program makes prostate cancer treatment decisions easier
When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance...
View ArticleAdded prostate CA criteria may help ID surveillance candidates
(HealthDay)—Additional predictors, such as prostate-specific antigen (PSA) density and extent of cancer on biopsy, help guide selection of prostate cancer patients for active surveillance programs,...
View ArticleStudy finds prostate cancer tests underestimate disease in half of cases
A study published in the British Journal of Cancer suggests that tests to grade and stage prostate cancer underestimated the severity of the disease in half of men whose cancers had been classified as...
View ArticleQuarter of prostate cancer patients may abandon 'watchful waiting' approach
(HealthDay)—Doctors often recommend no treatment at all when a man is diagnosed with prostate cancer, opting instead to keep a close eye on the slow-growing tumor and acting only when it becomes...
View Article
